Related changes

Jump to: navigation, search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 23:45, 17 September 2019
   
Page name:

16 September 2019

 m   17:24  Hodgkin lymphoma‎ (diff | hist) . . (+1). . Jwarner (talk | contribs) (Variant #3, uncapped vincristine {{#subobject:ff7478|Variant=1}})
 m   17:01  Waldenström macroglobulinemia‎ (diff | hist) . . (+1,177). . Jwarner (talk | contribs)
 m   16:19  Mantle cell lymphoma‎ (diff | hist) . . (+41). . Jwarner (talk | contribs) (BFR, then allo HSCT {{#subobject:c2659b|Regimen=1}})
 m   16:17  Follicular lymphoma‎‎ (2 changes | history) . . (+68). . [Jwarner‎ (2×)]
 m    16:17 (cur | prev) . . (+41). . Jwarner (talk | contribs) (Ibritumomab tiuxetan monotherapy {{#subobject:37ca7b|Regimen=1}})
 m    16:03 (cur | prev) . . (+27). . Jwarner (talk | contribs)

15 September 2019

 m   17:12  Diffuse large B-cell lymphoma‎‎ (6 changes | history) . . (+1,013). . [Jwarner‎ (6×)]
 m    17:12 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:60fc19|Variant=1}})
 m    16:58 (cur | prev) . . (+13). . Jwarner (talk | contribs) (Chemotherapy)
 m    16:57 (cur | prev) . . (+977). . Jwarner (talk | contribs)
 m    16:47 (cur | prev) . . (+10). . Jwarner (talk | contribs) (BR & Polatuzumab vedotin {{#subobject:1cc486|Regimen=1}})
 m    16:47 (cur | prev) . . (+3). . Jwarner (talk | contribs) (BR & Polatuzumab vedotin {{#subobject:1cc486|Regimen=1}})
 m    12:13 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:e3e516|Variant=1}})
     17:04  Chronic lymphocytic leukemia‎‎ (3 changes | history) . . (+1,562). . [Jwarner‎ (3×)]
      17:04 (cur | prev) . . (+1,545). . Jwarner (talk | contribs) (FCR {{#subobject:1dc12c|Regimen=1}})
 m    08:56 (cur | prev) . . (+15). . Jwarner (talk | contribs) (Alemtuzumab monotherapy {{#subobject:ab5318|Regimen=1}})
 m    08:55 (cur | prev) . . (+2). . Jwarner (talk | contribs) (Regimen {{#subobject:54cc87|Variant=1}})
     16:52  Follicular lymphoma‎‎ (4 changes | history) . . (+3,029). . [Jwarner‎ (4×)]
      16:52 (cur | prev) . . (+1,660). . Jwarner (talk | contribs)
 m    09:45 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #1 {{#subobject:f22c05|Variant=1}})
 m    09:45 (cur | prev) . . (+1,358). . Jwarner (talk | contribs) (Ibritumomab tiuxetan monotherapy {{#subobject:b0c8fb|Regimen=1}})
 m    09:39 (cur | prev) . . (+8). . Jwarner (talk | contribs) (Ibritumomab tiuxetan monotherapy {{#subobject:b0c8fb|Regimen=1}})
 m   16:40  Hairy cell leukemia‎‎ (2 changes | history) . . (+816). . [Jwarner‎ (2×)]
 m    16:40 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:3d2dea|Variant=1}})
 m    07:42 (cur | prev) . . (+811). . Jwarner (talk | contribs) (Cladribine monotherapy {{#subobject:dbcbf4|Regimen=1}})
 m   11:26  Hodgkin lymphoma‎ (diff | hist) . . (+5). . Jwarner (talk | contribs)
 m   11:25  Small cell lung cancer‎ (diff | hist) . . (+5). . Jwarner (talk | contribs)
 m   10:20  Cutaneous T-cell lymphoma‎ (diff | hist) . . (+21). . Jwarner (talk | contribs) (PUVA)

14 September 2019

 m   22:44  Cutaneous T-cell lymphoma‎ (diff | hist) . . (+10). . Jwarner (talk | contribs) (Vorinostat monotherapy {{#subobject:6a3a5b|Regimen=1}})
 m   22:04  Small cell lung cancer‎ (diff | hist) . . (+3). . Jwarner (talk | contribs) (Variant #2, 1.5 mg/m2 {{#subobject:a08066|Variant=1}})
 m   13:34  Hodgkin lymphoma‎‎ (2 changes | history) . . (+983). . [Jwarner‎ (2×)]
 m    13:34 (cur | prev) . . (+431). . Jwarner (talk | contribs) (MOPP {{#subobject:bcde0|Regimen=1}})
 m    13:32 (cur | prev) . . (+552). . Jwarner (talk | contribs) (MOPP {{#subobject:bcde0|Regimen=1}})
 m   11:02  Hairy cell leukemia‎ (diff | hist) . . (+589). . Jwarner (talk | contribs) (Interferon alfa-2b monotherapy {{#subobject:ca73f0|Regimen=1}})

13 September 2019

 m   23:48  Marginal zone lymphoma‎ (diff | hist) . . (+5). . Jwarner (talk | contribs) (Ibrutinib monotherapy {{#subobject:af879d|Regimen=1}})
 m   23:47  Waldenström macroglobulinemia‎‎ (2 changes | history) . . (+11). . [Jwarner‎ (2×)]
 m    23:47 (cur | prev) . . (+6). . Jwarner (talk | contribs)
 m    23:47 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Ibrutinib monotherapy {{#subobject:e206e9|Regimen=1}})
 m   23:45  Chronic lymphocytic leukemia‎‎ (3 changes | history) . . (-497). . [Jwarner‎ (3×)]
 m    23:45 (cur | prev) . . (-2). . Jwarner (talk | contribs)
 m    14:34 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Variant #2, 6 cycles {{#subobject:d30c3f|Variant=1}})
 m    14:31 (cur | prev) . . (-500). . Jwarner (talk | contribs)
 m   23:42  Mantle cell lymphoma‎ (diff | hist) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:529650|Variant=1}})
 m   20:32  Small cell lung cancer‎‎ (2 changes | history) . . (+641). . [Jwarner‎ (2×)]
 m    20:32 (cur | prev) . . (+621). . Jwarner (talk | contribs) (Cisplatin & Etoposide {{#subobject:ec90cd|Regimen=1}})
 m    13:52 (cur | prev) . . (+20). . Jwarner (talk | contribs)
 m   20:11  Cutaneous T-cell lymphoma‎‎ (2 changes | history) . . (+9). . [Jwarner‎ (2×)]
 m    20:11 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Regimen {{#subobject:4e103c|Variant=1}})
 m    20:10 (cur | prev) . . (+6). . Jwarner (talk | contribs) (Denileukin diftitox monotherapy {{#subobject:751a63|Regimen=1}})
 m   13:54  Hodgkin lymphoma‎ (diff | hist) . . (+10). . Jwarner (talk | contribs)

12 September 2019

 m   22:55  Follicular lymphoma‎‎ (2 changes | history) . . (+20). . [Jwarner‎ (2×)]
 m    22:55 (cur | prev) . . (+15). . Jwarner (talk | contribs)
 m    11:28 (cur | prev) . . (+5). . Jwarner (talk | contribs)
 m   22:53  Chronic lymphocytic leukemia‎‎ (4 changes | history) . . (+35). . [Jwarner‎ (4×)]
 m    22:53 (cur | prev) . . (+3). . Jwarner (talk | contribs)
 m    11:29 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:5cabd0|Variant=1}})
 m    11:27 (cur | prev) . . (+23). . Jwarner (talk | contribs)
 m    11:02 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Regimen {{#subobject:8e168d|Variant=1}})

11 September 2019

 m   18:07  Peripheral T-cell lymphoma‎ (diff | hist) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:fd7901|Variant=1}})
 m   18:07  Cutaneous T-cell lymphoma‎ (diff | hist) . . (+10). . Jwarner (talk | contribs) (Romidepsin monotherapy {{#subobject:b4c097|Regimen=1}})
 m   18:04  Chronic lymphocytic leukemia‎ (diff | hist) . . (+6). . Jwarner (talk | contribs)
 m   18:02  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+3). . Jwarner (talk | contribs) (Variant #4, prednisone 100 mg, flat-dose vincristine {{#subobject:bcb2bf|Variant=1}})